title: Point: A call for advanced pharmacokinetic and pharmacodynamic monitoring to guide calcineurin inhibitor dosing in renal transplant recipients.
authors.affiliation: Department of Clinical Chemistry, Leiden University Medical Center, Leiden, the Netherlands.
authors.forename: Huub H
authors.initials: HH
authors.lastname: van Rossum
authors.forename: Rogier R
authors.initials: RR
authors.lastname: Press
authors.forename: Jan
authors.initials: J
authors.lastname: den Hartigh
authors.forename: Johan W
authors.initials: JW
authors.lastname: de Fijter
mesh_terms: D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D016559:Tacrolimus / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D065095:Calcineurin Inhibitors; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus